CLINICAL_TRIALS
trial_result
· 2018-02-12
Clinical Trial Update: Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex [Phase 4]
Summary
Phase 4 clinical trial evaluating the effect of magnesium sulfate after reversal of rocuronium-induced neuromuscular blockade with sugammadex.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Neuromuscular Blockade | Phase 4 | Status: COMPLETED